We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

News · April 19, 2021

AACR 2021: Experimental Vaccine Incorporating Patient-Specific Neoantigen Peptides Shows Promise in Treatment of Malignancies

Proof-of-concept trial demonstrated feasibility, good tolerability, and hints of efficacy

PracticeUpdate Editorial Team

 

Further Reading